A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II.

In this study, DFT/B3LYP level of theory with the 6-31G (d) basis set, was used to calculate a set of molecular descriptors of 30 sulfonamide compounds with carbonic anhydrase inhibitory activity. Quantitative structure-activity relationship (QSAR) models of the biological activity (K(i)) of 30 inhibitors of carbonic anhydrase (CA-II) were established using some of the following calculated quantum mechanical descriptors, dipole moment (mu), average polarizability (P), ionization potential (I), electron affinity (A), LUMO energy (epsilon(LUMO)), HOMO energy (epsilon(HOMO)), total energy at 0K (Te), entropy at 298K (S), electronegativity (chi), hardness (eta), electrophilicity (omega), and differences between HOMO and LUMO energies (epsilon(H)-epsilon(L)). The QSAR models obtained by employing multiple linear regression techniques are aimed at correlating the structures to their reported experimental inhibitory activity values, K(i). Among the models presented in this study, statistically the most significant one is a four-parameter linear equation with correlation coefficient, R(2) values of ca. 0.847 and the cross-validated correlation coefficient, R values of ca. 0.775. This study also reconstructed the obtained models using AM1-based calculated descriptors to demonstrate the superiority of DFT over AM1 for quantum calculations of mechanical descriptors. The results are discussed in the light of the main factors that influence the inhibitory activity of carbonic anhydrase (CA-II) isozyme.

[1]  Claudiu T. Supuran,et al.  Predictive Flip Regression: A Technique for QSAR of Derivatives of Symmetric Molecules , 2005, J. Chem. Inf. Model..

[2]  Claudiu T. Supuran,et al.  Applications of carbonic anhydrase inhibitors and activators in therapy , 2002 .

[3]  J. Stewart.  Optimization of parameters for semiempirical methods I. Method , 1989 .

[4]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 41. Quantitative structure-activity correlations involving kinetic rate constants of 20 sulfonamide inhibitors from a non-congeneric series , 1997 .

[5]  Claudiu T. Supuran,et al.  Carbonic anhydrase inhibitors. Part 61. Quantum chemical QSAR of a group of benzenedisulfonamides , 1999 .

[7]  C. Supuran,et al.  A physically interpretable quantum-theoretic QSAR for some carbonic anhydrase inhibitors with diverse aromatic rings, obtained by a new QSAR procedure. , 2005, Bioorganic & medicinal chemistry.

[8]  M. Karelson.  Molecular descriptors in QSAR/QSPR , 2000 .

[9]  Ruth Pachter,et al.  Improved QSARs for Predictive Toxicology of Halogenated Hydrocarbons , 2000, Comput. Chem..

[10]  T. Maren,et al.  Carbonic anhydrase: General perspective and advances in glaucoma research , 1987 .

[11]  P. Khadikar,et al.  Modelling of carbonic anhydrase inhibitory activity of sulfonamides using molecular negentropy. , 2003, Bioorganic & medicinal chemistry letters.

[12]  Claudiu T Supuran,et al.  Indisulam: an anticancer sulfonamide in clinical development , 2003, Expert opinion on investigational drugs.

[13]  P. Khadikar,et al.  Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides. , 2004, Bioorganic & medicinal chemistry letters.

[14]  C. Supuran,et al.  Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. , 2003, Bioorganic & medicinal chemistry letters.

[15]  C. Supuran,et al.  Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. , 2003, Bioorganic & medicinal chemistry letters.

[16]  C. Supuran,et al.  Carbonic anhydrase inhibitors — Part 47: Quantum chemical quantitative structure-activity relationships for a group of sulfanilamide Schiff base inhibitors of carbonic anhydrase , 1998 .

[17]  R. H. Myers.  Classical and modern regression with applications , 1986 .

[18]  R. Parr,et al.  Absolute hardness: companion parameter to absolute electronegativity , 1983 .

[19]  J. Sudmeier,et al.  Cadmium-113 nuclear magnetic resonance studies of 113Cd(ii)-substituted human carbonic anhydrase B. , 1977, Journal of the American Chemical Society.

[20]  T. Maren,et al.  Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. , 1993, Molecular pharmacology.

[21]  Jian Wan,et al.  A DFT-based QSARs study of protoporphyrinogen oxidase inhibitors: phenyl triazolinones. , 2004, Bioorganic & medicinal chemistry.

[22]  H. K. Srivastava,et al.  Comparative QSAR study of phenol derivatives with the help of density functional theory. , 2005, Bioorganic & medicinal chemistry.

[23]  C. Supuran,et al.  Carbonic anhydrase inhibitors - Part 57 : Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties , 1999 .

[24]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[25]  R. Parr.  Density-functional theory of atoms and molecules , 1989 .

[26]  R. Parr,et al.  Electronegativity: The density functional viewpoint , 1978 .

[27]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[28]  Robert G. Parr,et al.  Activation hardness: new index for describing the orientation of electrophilic aromatic substitution , 1990 .

[29]  J. Stewart.  Optimization of parameters for semiempirical methods II. Applications , 1989 .

[30]  L. Pauling.  The Nature Of The Chemical Bond , 1939 .

[31]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. , 2005, Bioorganic & medicinal chemistry letters.

[32]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 24. A quantitative structure-activity relationship study of positively charged sulfonamide inhibitors , 1995 .

[33]  J. P. Bowen,et al.  Ab initio calculations and molecular mechanics (MM3) force field development for sulfonamide and its alkyl derivatives , 1997 .

[34]  Quantitative structure-activity relationship study on sulfanilamide schiff's bases: carbonic anhydrase (CA) inhibitors. , 2003, Bioorganic & medicinal chemistry.

[35]  Semi-empirical atomic charges and dipole moments in hypervalent sulfonamide molecules: descriptors in QSAR studies , 1998 .

[36]  R. Parr,et al.  Principle of maximum hardness , 1991 .